-Sung Il Yoon Researcher Activity Profile

Research Author Detailed Information 

Sung Il Yoon Publication Rate By Year

Sung Il Yoon has published 1 paper(s) in 2006, 8 paper(s) in 2007, 4 paper(s) in 2008, for a total of 13 research publications in total.

Sung Il Si Yoon Author Information

LAST NAME: yoon

FIRST NAME: Sung Il

INITIALS: si

AFFILIATION:

Papers

Sung Il Yoon's Publication Record

1. Conformational changes mediate interleukin-10 receptor 2 (IL-10R2) binding to IL-10 and assembly of the signaling complex. Year Published: 2006
Department of Microbiology and Center for Biophysical Sciences and Engineering, University of Alabama at Birmingham, Birmingham, Alabama 35294, USA.
2. Cholesterol reduction by methyl-beta-cyclodextrin attenuates the delta opioid receptor-mediated signaling in neuronal cells but enhances it in non-neuronal cells. Year Published: 2007
Department of Pharmacology, Center for Substance Abuse Research, Temple University School of Medicine, 3420 N Broad Street, Philadelphia, PA 19140, United States.
3. Identification and characterization of a +1 frameshift observed during the expression of Epstein-Barr virus IL-10 in Escherichia coli. Year Published: 2007
Department of Microbiology and Center for Biophysical Sciences and Engineering, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
4. Evaluation of physicochemical properties, skin permeation and accumulation profiles of ketorolac fatty ester prodrugs. Year Published: 2007
College of Pharmacy, Yeungnam University, Gyongsan, South Korea.
5. Brain region-specific N-glycosylation and lipid rafts association of the rat mu opioid receptor. Year Published: 2007
Department of Pharmacology, Center for Substance Abuse Research, Temple University School of Medicine, Philadelphia, PA 19140, USA.
6. Agonist treatment did not affect association of mu opioid receptors with lipid rafts and cholesterol reduction had opposite effects on the receptor-mediated signaling in rat brain and CHO cells. Year Published: 2007
Department of Pharmacology, Temple University School of Medicine, Philadelphia, PA, USA; Department of Biochemistry, Temple University School of Medicine, Philadelphia, PA, USA.
7. Evaluation of physicochemical properties, skin permeation and accumulation profiles of ketorolac fatty ester prodrugs. Year Published: 2007
College of Pharmacy, Yeungnam University, Gyongsan, South Korea.
8. Agonist treatment did not affect association of mu opioid receptors with lipid rafts and cholesterol reduction had opposite effects on the receptor-mediated signaling in rat brain and CHO cells. Year Published: 2007
Department of Pharmacology, Temple University School of Medicine, Philadelphia, PA 19140, USA.
9. Brain region-specific N-glycosylation and lipid rafts association of the rat mu opioid receptor. Year Published: 2007
Department of Pharmacology, Center for Substance Abuse Research, Temple University School of Medicine, Philadelphia, PA 19140, USA.
10. Structure and mechanism of IFN-gamma antagonism by an orthopoxvirus IFN-gamma-binding protein. Year Published: 2008
Center for Biophysical Sciences and Engineering, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
11. Structure and mechanism of IFN-gamma antagonism by an orthopoxvirus IFN-gamma-binding protein. Year Published: 2008
Center for Biophysical Sciences and Engineering, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
12. Evaluation of skin permeation and accumulation profiles of a highly lipophilic fatty ester. Year Published: 2008
College of Pharmacy, Yeungnam University, Gyongsan 712-749, Korea.
13. Structure and mechanism of IFN-gamma antagonism by an orthopoxvirus IFN-gamma-binding protein. Year Published: 2008
Center for Biophysical Sciences and Engineering, University of Alabama at Birmingham, Birmingham, AL 35294, USA.